NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Stents


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Findings from Purdue University broaden understanding of microwave research
2009 NOV 24 ... "In this study, we explore the use of stents as radiating structures to support transcutaneous wireless telemetry for data transfer ...
Subject: Microwave Research
Price: $3.00
*
Higher carotid arterial stenting rates associated with poorer clinical outcomes
2009 NOV 23 ... Medical Center, has researched the impact of cardiac devices, including drug-eluting stents and implantable cardioverter-defibrillators, for more than 15 years, notes that in a ...
Subject: University of Pennsylvania School of Medicine
Price: $3.00
*
New cardiology study findings have been reported by D.T. Ko and co-researchers
2009 NOV 23 ... "Twelve months of uninterrupted thienopyridine therapy after drug-eluting stents (DES) implantation was recently recommended, but limited data are available regarding ...
Subject: Cardiology
Price: $3.00
*
New nephrolithotomy research from A.K. Srinivasan et al outlined
2009 NOV 24 ... the different techniques of renal drainage after PCNL-ie, nephrostomy tube, ureteral stents, and totally tubeless strategy with critical discussion of available evidence for and ...
Subject: Nephrolithotomy
Price: $3.00
*
New thrombosis findings from E. Dilorenzo and co-authors described
2009 NOV 23 ... and colleagues published their study in American Heart Journal (Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: Four year ...
Subject: Thrombosis
Price: $3.00
*
New tissue engineering study findings reported from Cleveland Clinic
2009 NOV 23 ... "Current data show conflicting results regarding safety and efficacy of drug-eluting stents (DES) versus bare-metal stents (BMS) for treating ...
Subject: Tissue Engineering
Price: $3.00
*
Reports from Columbia University highlight recent research in heart disease
2009 NOV 23 ... the absolute benefits of EES." "The relative efficacy of these 2 stents, in patients with diabetes mellitus also remains controversial. We therefore designed a ...
Subject: Heart Disease
Price: $3.00
*
Reports on anesthesia findings from T. Elhusseiny and co-researchers provide new insights
2009 NOV 23 ... stone free after adjuvant shockwave lithotripsy. Two patients needed temporary Double-J stents. One renal access failed. Two procedures were aborted because of hemorrhage. One patient ...
Subject: Anesthesia
Price: $3.00
*
Reports outline veterinary medical science research from R. Choi and colleagues
2009 NOV 23 ... placement using a self-expanding nitinol intraluminal stent (Zilver ® 535 biliary stents, COOK ®, U.S.A.) subsequent with balloon expansion. Although the cat showed 2 days ...
Subject: Veterinary Medical Science
Price: $3.00
*
Research from B.K. Kim and co-researchers yields new findings on thrombosis
2009 NOV 23 ... (Long-Term Clinical Outcomes and Stent Thrombosis of Sirolimus-Eluting Versus Bare Metal Stents in Patients with End-Stage Renal Disease: Results of Korean Multicenter Angioplasty Team ...
Subject: Thrombosis
Price: $3.00
*
Research from S. Silber and co-researchers in the area of life sciences published
2009 NOV 23 ... infarction were low and similar between groups, with 2 stent thromboses with bare-metal stents compared with no event beyond 2 years with either of the TAXUS...
Subject: Life Sciences
Price: $3.00
*
Research on colorectal stents discussed by scientists at Kaiser Permanente
2009 NOV 23 ... who underwent stenting at a tertiary center over 4 years. One surgeon performed all stents under endoscopic and fluoroscopic guidance. A total of 49 stent procedures were ...
Subject: Colorectal Stents
View Free
Daily News
Article
Researchers from New York Medical College, Medical College report recent findings in life sciences
2009 NOV 23 ... PCI. Of the 634 patients, 319 (50%) had a single stent, and 315 (50%) had multiple stents inserted." "Stepwise Cox regression analyses were performed to identify ...
Subject: Life Sciences
Price: $3.00
*
Study findings from University of Glasgow provide new insights into life sciences
2009 NOV 23 ... According to a study from Scotland, "We aimed to analyze trends in drug-eluting stents. (DES) use in four international health care and regulatory settings. Accounts suggest a ...
Subject: Life Sciences
Price: $3.00
*
This Essential 2009 Research Report Analyzes the Gastrointestinal GI Endoscopy Devices Worldwide Market
2009 NOV 23 ... Devices (balloons/ baskets), ERCP cannulae, Guidewires, Sphincterotomes Stents: Biliary Metal Stents, Esophageal Metal...
Subject: Research and Markets Ltd.
Price: $3.00
*
Viron to Present Data from Phase II Trial at American Heart Association Conference
2009 NOV 23 ... a serine protein inhibitor, in patients with Acute Coronary Syndromes receiving coronary stents. Dr. Tardif's presentation is scheduled for Wednesday, November 18, 2009, at 11:00 AM ...
Subject: Viron Therapeutics Inc.
Price: $3.00
*
VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Arterial Disease
2009 NOV 23 ... stent (Atrium Medical Corporation, Hudson, NH) to bare-metal stents (BMS) in patients with iliac occlusive disease. The data showed a statistically ...
Subject: VIVA Physicians, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login